UNSPSC 51302004: Tolnaftate

This classification denotes an antifungal agent with the molecular formula C19H17NOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 06KB629TKV, chemically known as o-2-naphthyl n,n-dimethylthiocarbanilate but generally known as tolnaftate, which bears US NIH Compound Identifier 5510. European Medicines Agency schedules Tolnaftate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11163MIG. The term TOLNAFTATE is an International Non-Proprietary Name.

UNSPSC 51302004 Tolnaftate, a Commodity code, does not align with the recent state and local solicitations tagged under it. The code nominally describes an antifungal pharmaceutical agent, but the two recent opportunities posted under this code — a City of Austin invitation to bid for liquid aluminum sulfate (alum) for wastewater treatment and a City of Tampa invitation to bid for medical aid supplies including antiseptic sprays, bandages, and first aid items — involve chemical treatment products and general medical supplies unrelated to tolnaftate. The mismatch suggests either a cataloging error in the underlying procurement records or a significant divergence between the code's intended scope and its application in practice. State and local procurement bodies do not appear to be actively sourcing tolnaftate specifically under this code.

The two recorded opportunities reflect different issuing bodies and geographies: the City of Austin (Texas) is procuring alum for wastewater treatment operations with bids due August 25, 2026, while the City of Tampa (Florida) solicited general medical supplies through an ITB with a bid opening date of April 9, 2025 (already closed). Neither opportunity represents actual tolnaftate procurement. Without recent, on-code opportunities from state and local buyers, this code presents no actionable activity for business development targeting the antifungal-pharmaceutical segment. Verification of the code assignment or review of procurement records from states with higher utilization of pharmaceutical commodities may clarify whether tolnaftate solicitations appear under a different UNSPSC classification.